Performance Food Group insider files Form 144 to sell 4,316 shares

Rhea-AI Filing Summary

Performance Food Group Company (PFGC) filed a Form 144 reporting a proposed sale of 4,316 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $428,665.12. The filing shows the shares were acquired from the issuer on 08/19/2025 under a PSA and payment was made the same day. The sale is slated to occur on or about 08/20/2025. The filer has recorded prior Rule 10b5-1 sales in the past three months: 1,529 shares on 08/19/2025 for $152,365.00 and 8,200 shares on 05/29/2025 for $735,680.22. Outstanding shares are listed as 156,519,106.

Positive

• Transparent disclosure of proposed insider sale with broker, amounts, and dates provided
• Use of Rule 10b5-1 plans for prior sales, which supports orderly and preplanned trading

Negative

• Insider selling activity: 9,729 shares sold in the past three months could attract investor attention
• Short interval between acquisition and proposed sale: shares acquired 08/19/2025 under PSA and proposed sale 08/20/2025

Insights

Securities Analyst

TL;DR Routine insider sale notice; notable for recent concentrated 10b5-1 activity by the same holder.

This Form 144 documents a planned sale of 4,316 shares valued at $428,665.12 and confirms the holder executed prior 10b5-1 program sales totaling 9,729 shares in the past three months. As a disclosure filing, it provides transparency on insider liquidity but does not by itself convey operational or financial changes at the company. Investors monitoring insider activity may consider the volume relative to the 156.5 million shares outstanding; here the transactions are immaterial to capitalization but relevant for insider trading patterns.

Corporate Governance Expert

TL;DR The filing appears compliant and references Rule 10b5-1 sales; no governance red flags in the notice itself.

The Form 144 indicates the seller attests to lack of undisclosed material information and cites a PSA acquisition and 10b5-1 execution history. The presence of multiple 10b5-1 sales suggests the holder is using preplanned trading arrangements, which is standard practice to mitigate insider trading concerns. The filing contains the required broker, amounts, and dates, satisfying disclosure norms for an insider disposition.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4316	428665.12	156519106	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	PSA	Issuer			4316	08/19/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	08/19/2025	1529	152365.00
10b5-1 Sales for ERIKA T. DAVIS 12500 West Creek Parkway Richmond VA 23238	Common	05/29/2025	8200	735680.22

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for PFGC report?

The filing reports a proposed sale of 4,316 common shares through Morgan Stanley with aggregate market value $428,665.12 and an approximate sale date of 08/20/2025.

Who is the seller named in the Form 144 for PFGC?

The past sales listed identify Erika T. Davis at the provided address as the seller for prior 10b5-1 transactions.

Were there recent sales by this holder before the Form 144 filing?

Yes. The holder sold 1,529 shares on 08/19/2025 for $152,365.00 and 8,200 shares on 05/29/2025 for $735,680.22 under 10b5-1 arrangements.

How many shares outstanding does PFGC report on the Form 144?

The filing lists 156,519,106 shares outstanding.

What acquisition details are provided for the shares to be sold?

The 4,316 shares were acquired from the issuer on 08/19/2025 under a PSA and payment date is listed as 08/19/2025.